Abstract: The present invention discloses a salt derivative of 1-(3-methanesulfonamidobenzyl)-6-methoxy-7-benzyloxy-1,2,3,4-tetrahydroisoquinoline. The salt derivative has a solubility in water of not less than 3.0 nmol/mL or 1.8 mg/mL. The salt derivative has a solubility in water of not less than 3.0 nmol/mL or 1.8 mg/mL.

Abstract: Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.

Abstract: Disclosed are a method for preparing a dabigatran etexilate intermediate, and an intermediate compound. The method for preparing a dabigatran etexilate intermediate 4 comprises: reacting a compound 3 with a C1-C3 alkyl alcohol solution of methylamine in an organic solvent, wherein, X=chlorine, bromine, or iodine. Also disclosed are an intermediate compound 3 and a preparation method thereof. The method for preparing a dabigatran etexilate intermediate of the present invention has the advantages of simple process, easy operation, high yield, and easy purification, thus being suitable for industrial production.

Abstract: Disclosed are a platinum (II) compound, a preparation method therefor, and a pharmaceutical composition and an application thereof. The preparation method comprises the following steps: enabling dihydrate diammine platinum nitrate (4) to react with the carboxylate ligand derivative (5) in water, to produce a platinum (II) compound. Also provided are an application of the platinum (II) compound in preparation of an antitumor drug, and a pharmaceutical composition. The pharmaceutical composition contains an active component and a medicinal carrier, the active component containing the platinum (II) compound, and the mass percentage of the active component being 0.1%-95%. The platinum (II) compound of the present invention is well water-soluble, low toxic, easily prepared, and efficient in antitumor activity.

Abstract: Disclosed are a platinum (II) compound, a preparation method therefor, and a pharmaceutical composition and an application thereof. The preparation method comprises the following steps: enabling dihydrate diammine platinum nitrate (4) to react with the carboxylate ligand derivative (5) in water, to produce a platinum (II) compound. Also provided are an application of the platinum (II) compound in preparation of an antitumor drug, and a pharmaceutical composition. The pharmaceutical composition contains an active component and a medicinal carrier, the active component containing the platinum (II) compound, and the mass percentage of the active component being 0.1%-95%. The platinum (II) compound of the present invention is well water-soluble, low toxic, easily prepared, and efficient in antitumor activity.

Abstract: Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.

Abstract: The present invention relates to a treatment of high-level waste of radiochemical production containing radionuclides and macro-admixtures including sodium. The method of extraction of radionuclides by processing acidic aqueous waste solutions by extractants containing macrocyclic compounds selected from the group of crown ethers having aromatic fragments containing alkyl and/or hydroxyalkyl substituents of a linear and/or branched structure, and/or cyclohexane fragments containing alkyl and/or hydroxyalkyl substituents of a linear and/or branched structure, and/or fragments of —O—CHR—CH2O—, where R is the normal or branched alkyl or hydroxyalkyl in organic solvents containing polyfluorinated telomeric alcohol 1,1,7-trihydrododecafluoroheptanol-1 having the formula H(CF2CF2)nCH2OH, where n=3, and a mixture of polyoxyethylene glycol ethers of synthetic primary higher aliphatic alcohols of a fraction C12-C14 of a general formula CnH2n+1O(C2H4O)mH, where n=12-14, m=2 is proposed.

Abstract: An apparatus for electrolytic production of magnesium includes a plurality of upright anode elements interspread with a plurality of cathode elements situated within at least one electrolysis compartment. At least one section, defined between two adjacent anodes and having an elongated loading inlet, is provided for receiving and melting of a substantially solid raw material. A gas discharging outlet is formed for discharging of chlorine gas developed at the plurality of anodes. A baffle is supported by the receiving anodes in the vicinity of the gas discharging outlet. The baffle prevents direct flow of a mixture of chlorine gas and fine dust particles resulted from loading of the solid raw material between the section and gas discharging outlet.